• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小剂量多巴酚丁胺超声心动图在预测双心室起搏反应中的作用。心脏再同步治疗(ViaCRT)多中心研究结果

Role of low‑dose dobutamine echocardiography in predicting response to biventricular pacing. Results from the multicenter Viability in Cardiac Resynchronisation Therapy (ViaCRT) study.

作者信息

Płońska-Gościniak Edyta, Kasprzak Jarosław D, Kukulski Tomasz, Mizia-Stec Katarzyna, Nowalany-Kozielska Ewa, Gąsior Zbigniew, Wita Krystian, Sinkiewicz Władysław, Szwed Hanna, Gościniak Piotr, Chrzanowski Łukasz

出版信息

Pol Arch Med Wewn. 2016 Dec 12;126(12):989-994. doi: 10.20452/pamw.3715.

DOI:10.20452/pamw.3715
PMID:27958262
Abstract

INTRODUCTION    The response to Cardiac Resynchronisation Therapy (CRT) varies significantly, resulting in lack of improvement among the substantial patients proportion.  OBJECTIVES    To identify mechanical dyssynchrony indices with combination of myocardial viability characteristics for predicting long-term response to CRT.  PATIENTS AND METHODS    ViaCRT was a multicentre study coordinated by the Working Group on Echocardiography of  Polish Cardiac Society. 127 patients with heart failure were assessed prospectively. Cardiac dyssynchrony indices and low-dose dobutamine response were determined by echocardiography prior to CRT. Improvement in Wall Motion Score Index (WMSI) or LVEF exceeding 20% at peak stress identified preserved contractile reserve.  RESULTS    After 12 months there was significantly different survival between subsets with and without viability characterised by WMSI decrease, corresponding to 1 (4.4%) and 20 (19.4%) fatal events respectively (p=0.048). The predictive value of LVEF gain at Dobutamine Stress Echocardiography (DSE) study was only significant at 6 months, with all-cause death occurring in 1 (1.6%) and 7 (12.1%) of patients with viable and non-viable myocardium respectively (p=0.029). Multivariate regression analysis identified the presence of septal flash and interventricular dyssynchrony as independent indices with the ability to predict echocardiographic response alone at 12 months. CONCLUSIONS    The study demonstrated a significant relationship between left ventricular contractile reserve at DSE and long-term all-cause mortality following CRT device implantation. Conversely, the presence of septal flash and interventricular dyssynchrony but not myocardial viability were predictive of the response to resynchronisation. The results indicate that interference of multiple different mechanisms may be responsible for the general effect following CRT.

摘要

引言

心脏再同步治疗(CRT)的反应差异显著,导致相当一部分患者并无改善。

目的

结合心肌存活特征识别机械不同步指标,以预测CRT的长期反应。

患者与方法

ViaCRT是由波兰心脏病学会超声心动图工作组协调的一项多中心研究。前瞻性评估了127例心力衰竭患者。在CRT治疗前通过超声心动图测定心脏不同步指标和低剂量多巴酚丁胺反应。壁运动评分指数(WMSI)改善或峰值应力时左室射血分数(LVEF)增加超过20%表明保留收缩储备。

结果

12个月后,以WMSI降低为特征的有存活能力和无存活能力亚组之间的生存率有显著差异,分别对应1例(4.4%)和20例(19.4%)死亡事件(p=0.048)。多巴酚丁胺负荷超声心动图(DSE)研究中LVEF增加的预测价值仅在6个月时显著,有存活心肌和无存活心肌的患者全因死亡分别发生1例(1.6%)和7例(12.1%)(p=0.029)。多变量回归分析确定室间隔闪烁和心室间不同步的存在是独立指标,能够单独预测12个月时的超声心动图反应。

结论

该研究表明DSE时左室收缩储备与CRT装置植入后的长期全因死亡率之间存在显著关系。相反,室间隔闪烁和心室间不同步的存在而非心肌存活能力可预测再同步反应。结果表明多种不同机制的干扰可能是CRT后总体效果的原因。

相似文献

1
Role of low‑dose dobutamine echocardiography in predicting response to biventricular pacing. Results from the multicenter Viability in Cardiac Resynchronisation Therapy (ViaCRT) study.小剂量多巴酚丁胺超声心动图在预测双心室起搏反应中的作用。心脏再同步治疗(ViaCRT)多中心研究结果
Pol Arch Med Wewn. 2016 Dec 12;126(12):989-994. doi: 10.20452/pamw.3715.
2
Dynamic relationship of left-ventricular dyssynchrony and contractile reserve in patients undergoing cardiac resynchronization therapy.心脏再同步治疗患者左心室收缩不同步与收缩储备的动态关系。
Eur Heart J. 2014 Jan;35(1):48-55. doi: 10.1093/eurheartj/eht294. Epub 2013 Aug 4.
3
Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.超声心动图负荷试验作为心脏再同步治疗反应者识别方法的前瞻性验证
Heart Rhythm. 2006 Apr;3(4):406-13. doi: 10.1016/j.hrthm.2005.12.017.
4
Global myocardial contractile reserve assessed by high-dose dobutamine stress echocardiography predicts response to the cardiac resynchronization therapy.通过高剂量多巴酚丁胺负荷超声心动图评估的整体心肌收缩储备可预测心脏再同步治疗的反应。
Echocardiography. 2015 Mar;32(3):490-5. doi: 10.1111/echo.12694. Epub 2014 Jul 24.
5
Echocardiographic markers of dyssynchrony as predictors of super-response to cardiac resynchronisation therapy - a pilot study.心脏再同步治疗超反应预测因素——失同步的超声心动图标志物:一项初步研究
Cardiovasc Ultrasound. 2018 Oct 2;16(1):24. doi: 10.1186/s12947-018-0140-0.
6
Contractile reserve assessed using dobutamine echocardiography predicts left ventricular reverse remodeling after cardiac resynchronization therapy: prospective validation in patients with left ventricular dyssynchrony.使用多巴酚丁胺超声心动图评估的收缩储备可预测心脏再同步治疗后左心室逆向重构:左心室不同步患者的前瞻性验证
Echocardiography. 2010 Jul;27(6):668-76. doi: 10.1111/j.1540-8175.2009.01106.x. Epub 2010 Mar 25.
7
Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study.低剂量多巴酚丁胺试验与室间不同步相关:一种识别心脏再同步治疗反应者的有用工具:来自心脏再同步治疗的低剂量多巴酚丁胺负荷超声心动图试验(LODO-CRT)阶段 2 研究的数据。
Am Heart J. 2012 Mar;163(3):422-9. doi: 10.1016/j.ahj.2011.11.015. Epub 2012 Jan 20.
8
Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices.超声心动图预测心脏再同步治疗6个月及晚期反应:负荷超声心动图的应用及与广泛使用的不同步指数的比较评估
Int J Cardiovasc Imaging. 2019 Feb;35(2):285-294. doi: 10.1007/s10554-018-01520-6. Epub 2019 Jan 8.
9
Are changes in heart rate, observed during dobutamine stress echocardiography, associated with a response to cardiac resynchronisation therapy in patients with severe heart failure? Results of a multicentre ViaCRT study.多巴酚丁胺负荷超声心动图检查中心率变化与重度心力衰竭患者心脏再同步化治疗反应的关系:多中心 ViaCRT 研究结果。
Kardiol Pol. 2018;76(3):611-617. doi: 10.5603/KP.a2017.0261. Epub 2018 Jan 3.
10
Stress echocardiography for selecting potential responders to cardiac resynchronisation therapy.超声心动图应激试验筛选心脏再同步化治疗潜在反应者
Heart. 2010 Jul;96(14):1142-6. doi: 10.1136/hrt.2010.199828.

引用本文的文献

1
Stress echocardiography. Part II: Stress echocardiography in conditions other than coronary heart disease.负荷超声心动图。第二部分:冠心病以外情况下的负荷超声心动图
J Ultrason. 2019;19(76):49-53. doi: 10.15557/JoU.2019.0007.
2
Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices.超声心动图预测心脏再同步治疗6个月及晚期反应:负荷超声心动图的应用及与广泛使用的不同步指数的比较评估
Int J Cardiovasc Imaging. 2019 Feb;35(2):285-294. doi: 10.1007/s10554-018-01520-6. Epub 2019 Jan 8.
3
The Role of Echocardiography in the Optimization of Cardiac Resynchronization Therapy: Current Evidence and Future Perspectives.
超声心动图在心脏再同步治疗优化中的作用:当前证据与未来展望
Open Cardiovasc Med J. 2017 Dec 19;11:133-145. doi: 10.2174/1874192401711010133. eCollection 2017.